KAIST researchers have discovered a molecular switch that can revert cancer cells back to normal by capturing the critical ...
BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...
The University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early ...
5d
News Medical on MSNUniversity of Oulu advances biosensor technology for disease detectionThe University of Oulu is at the forefront of developing cutting-edge biosensor technology that could revolutionize the early diagnosis and treatment of diseases.
1d
GlobalData on MSNEU reshapes HTAs: is the industry ready for it?New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...
The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...
Q4 2023 Management View CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed ...
After urgent changes brought by team boss James Vowles ahead of F1 2024 caused last year’s Williams to be built late and ...
Near-term opportunities for Air Liquide come from blue hydrogen in the U.S., while green hydrogen is a bigger and ...
Kim Gun-ho, CEO of Recens Medical (left), and Kim Sung-su, Executive Director of Yuhan Corporation, are posing for a ...
Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results